Procter & Gamble Health Limited - Asset Resilience Ratio

Latest as of September 2025: 33.01%

Procter & Gamble Health Limited (PGHL) has an Asset Resilience Ratio of 33.01% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read PGHL liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

Rs2.95 Billion

≈ $31.93 Million USD Cash + Short-term Investments

Total Assets

Rs8.94 Billion

≈ $96.73 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2003–2024)

This chart shows how Procter & Gamble Health Limited's Asset Resilience Ratio has changed over time. See PGHL net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Procter & Gamble Health Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Procter & Gamble Health Limited stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs2.79 Billion	31.23%
Short-term Investments	Rs159.40 Million	1.78%
Total Liquid Assets	Rs2.95 Billion	33.01%

Asset Resilience Insights

Very High Liquidity: Procter & Gamble Health Limited maintains exceptional liquid asset reserves at 33.01% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Procter & Gamble Health Limited Industry Peers by Asset Resilience Ratio

Compare Procter & Gamble Health Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	9.09%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.02%
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	Drug Manufacturers - Specialty & Generic	0.01%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%

Annual Asset Resilience Ratio for Procter & Gamble Health Limited (2003–2024)

The table below shows the annual Asset Resilience Ratio data for Procter & Gamble Health Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	14.33%	Rs1.14 Billion ≈ $12.31 Million	Rs7.94 Billion ≈ $85.89 Million	-6.95pp
2023-12-31	21.27%	Rs1.69 Billion ≈ $18.28 Million	Rs7.94 Billion ≈ $85.91 Million	-11.18pp
2022-12-31	32.45%	Rs3.57 Billion ≈ $38.65 Million	Rs11.01 Billion ≈ $119.09 Million	-5.27pp
2021-12-31	37.72%	Rs3.37 Billion ≈ $36.46 Million	Rs8.94 Billion ≈ $96.65 Million	-5.76pp
2020-12-31	43.48%	Rs4.29 Billion ≈ $46.37 Million	Rs9.86 Billion ≈ $106.65 Million	-7.40pp
2019-12-31	50.88%	Rs5.99 Billion ≈ $64.73 Million	Rs11.76 Billion ≈ $127.22 Million	+18.21pp
2018-12-31	32.67%	Rs5.75 Billion ≈ $62.17 Million	Rs17.59 Billion ≈ $190.28 Million	+25.61pp
2017-12-31	7.06%	Rs699.70 Million ≈ $7.57 Million	Rs9.91 Billion ≈ $107.20 Million	+3.91pp
2016-12-31	3.15%	Rs277.80 Million ≈ $3.00 Million	Rs8.83 Billion ≈ $95.47 Million	-2.25pp
2015-12-31	5.39%	Rs422.80 Million ≈ $4.57 Million	Rs7.84 Billion ≈ $84.78 Million	+2.02pp
2014-12-31	3.37%	Rs238.70 Million ≈ $2.58 Million	Rs7.08 Billion ≈ $76.59 Million	-0.37pp
2013-12-31	3.74%	Rs242.90 Million ≈ $2.63 Million	Rs6.49 Billion ≈ $70.14 Million	-0.23pp
2012-12-31	3.98%	Rs236.40 Million ≈ $2.56 Million	Rs5.94 Billion ≈ $64.27 Million	-17.82pp
2006-12-31	21.80%	Rs1.04 Billion ≈ $11.30 Million	Rs4.79 Billion ≈ $51.84 Million	+0.55pp
2005-12-31	21.25%	Rs823.10 Million ≈ $8.90 Million	Rs3.87 Billion ≈ $41.90 Million	+7.70pp
2004-12-31	13.54%	Rs442.80 Million ≈ $4.79 Million	Rs3.27 Billion ≈ $35.36 Million	+2.75pp
2003-12-31	10.79%	Rs300.00 Million ≈ $3.24 Million	Rs2.78 Billion ≈ $30.07 Million	--

pp = percentage points

About Procter & Gamble Health Limited

NSE:PGHL India Drug Manufacturers - Specialty & Generic

Market Cap

$936.52 Million

Rs86.60 Billion INR

Market Cap Rank

#9388 Global

#443 in India

Share Price

Rs5216.90

Change (1 day)

+1.59%

52-Week Range

Rs4778.60 - Rs6581.50

All Time High

Rs6870.36